112 related articles for article (PubMed ID: 17026517)
21. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors.
Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G
J Thorac Oncol; 2006 Jun; 1(5):468-77. PubMed ID: 17409901
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
23. [Lung metastases in a primitive neuroectodermal tumor].
Todea D; Rosca L
Pneumologia; 2007; 56(1):35-7. PubMed ID: 17491207
[TBL] [Abstract][Full Text] [Related]
24. CD163 is not a sensitive marker for identification of atypical fibroxanthoma.
Beer TW
J Cutan Pathol; 2012 Jan; 39(1):29-32. PubMed ID: 22211334
[TBL] [Abstract][Full Text] [Related]
25. Atypical fibroxanthoma presenting immunoreactivity against CD10 and CD99.
Nakamura Y; Abe Y; Ichimiya M; Muto M
J Dermatol; 2010 Apr; 37(4):387-9. PubMed ID: 20507414
[No Abstract] [Full Text] [Related]
26. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
28. Primitive neuroectodermal tumor of the pancreas. An extremely rare tumor. Case report and review of the literature.
Bülchmann G; Schuster T; Haas RJ; Joppich I
Klin Padiatr; 2000; 212(4):185-8. PubMed ID: 10994548
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
30. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis.
Dorfman DM; Kraus M; Perez-Atayde AR; Barnhill RL; Pinkus GS; Granter SR
Mod Pathol; 1997 Apr; 10(4):283-8. PubMed ID: 9110288
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
32. Modulation of CD99/MIC2 expression of human AHTO-7 osteoblasts by carcinoma cell line-conditioned media.
Hamilton D; Mallinger R; Millesi H; Engel A; Baumgartner G; Raderer M
Anticancer Res; 2001; 21(6A):3909-13. PubMed ID: 11911268
[TBL] [Abstract][Full Text] [Related]
33. CD99 expression in hepatocellular carcinoma: an immunohistochemical study in the fibrolamellar and common variant of the tumour.
Vasdev N; Nayak NC
Indian J Pathol Microbiol; 2003 Oct; 46(4):625-9. PubMed ID: 15025359
[TBL] [Abstract][Full Text] [Related]
34. CD99 - much ado about nothing?
Pozdnyakova O; Mahalingam M
J Cutan Pathol; 2008 Jan; 35(1):86-7. PubMed ID: 18096002
[No Abstract] [Full Text] [Related]
35. CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.
Czapiewski P; Wełnicka-Jaśkiewicz M; Seroczyńska B; Skokowski J; Sejda A; Szade J; Wiewiora C; Biernat W; Żaczek A
Pol J Pathol; 2015 Sep; 66(3):269-75. PubMed ID: 26619106
[TBL] [Abstract][Full Text] [Related]
36. Expression of CD99 in pleomorphic carcinomas of the lung.
Yoo SH; Han J; Kim TJ; Chung DH
J Korean Med Sci; 2005 Feb; 20(1):50-5. PubMed ID: 15716602
[TBL] [Abstract][Full Text] [Related]
37. Paranuclear dot-like immunostaining of CD99 in rhabdomyosarcoma.
Huang SH; Wu SY; Chang KC
Histopathology; 2013 Apr; 62(5):814-6. PubMed ID: 23347163
[No Abstract] [Full Text] [Related]
38. Primary Ewing sarcoma of lumbar spine with massive intraspinal extension.
Song X; Choi J; Rao C; Nallu S; Nicastri AD
Pediatr Neurol; 2008 Jan; 38(1):58-60. PubMed ID: 18054697
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of CD99 in stomach cancer.
Jung KC; Park WS; Bae YM; Hahn JH; Hahn K; Lee H; Lee HW; Koo HJ; Shin HJ; Shin HS; Park YE; Park SH
J Korean Med Sci; 2002 Aug; 17(4):483-9. PubMed ID: 12172043
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
Fellinger EJ; Garin-Chesa P; Triche TJ; Huvos AG; Rettig WJ
Am J Pathol; 1991 Aug; 139(2):317-25. PubMed ID: 1867320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
